拓新药业：全资子公司产品甘磷酸胆碱通过美国Self-GRAS认证

Core Viewpoint - The company, Tuoxin Pharmaceutical, announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd., has successfully obtained Self-GRAS status for its product, Glyceryl Phosphoryl Choline, following a rigorous scientific evaluation in accordance with the FDA's Generally Recognized as Safe (GRAS) criteria [1] Group 1 - The product Glyceryl Phosphoryl Choline has completed a strict scientific evaluation [1] - The Self-GRAS status indicates that the product is recognized as safe for its intended use [1] - This achievement may enhance the company's market position and product credibility in the pharmaceutical industry [1]